Table Of Contents
1. Market Context & Strategic Relevance
1.1 Opening Context (Why the market matters)
1.1.1 Why This Market Is Gaining Strategic Attention
1.1.2 Business Decisions This Report Supports
1.2 Scope
1.3 Research & Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Product and Service
2.3.2 Market Size By Technology
2.3.3 Market Size By Application
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 RNA Extraction, Library Preparation Reagent & Flow Cell Suppliers
3.4.2 RNA Sequencing Platform & Sample Preparation Product Manufacturers
3.4.3 Sequencing Service Providers, Bioinformatics & Data Storage Vendors
3.4.4 Pharmaceutical Companies, Clinical Laboratories & Research Institutes
3.5 Industry Life Cycle Assessment
4. Statistical Insights & Trends Reporting
4.1 Transcriptomics Research & Clinical Use Indicators
4.1.1 Transcriptome Profiling Study Volumes
4.1.2 Single-Cell RNA Sequencing Project Counts
4.1.3 Clinical RNA-Based Test Volumes
4.1.4 Public Transcriptomic Dataset Growth
4.2 Sequencing Technology Adoption Metrics
4.2.1 Sequencing by Synthesis Platform Share
4.2.2 Long-Read RNA Sequencing Adoption
4.2.3 Direct RNA Nanopore Sequencing Use
4.2.4 Spatial Transcriptomics Integration
4.3 Cost per Sample & Pricing Trends
4.3.1 RNA-Seq Cost per Sample
4.3.2 Library Preparation Kit Pricing
4.3.3 Data Storage and Analysis Costs
4.3.4 Service Price per Project
4.4 Regulatory, Data & Quality Standards Environment
4.4.1 Clinical Sequencing Assay Regulation
4.4.2 Genomic Data Privacy Rules
4.4.3 Laboratory Accreditation Standards
4.4.4 Research Data Sharing Requirements
4.5 Application Demand Indicators
4.5.1 Drug Discovery Transcriptome Screening
4.5.2 Oncology and Rare Disease Clinical Diagnostics
4.5.3 Biomarker and Translational Research Programs
4.5.4 Academic Basic Research Demand
5. NGS-based RNA Sequencing Market Segmental Analysis & Forecast, By Product and Service, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 RNA-Seq Platforms and Consumables
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 Sample Preparation Products
5.4 RNA-Seq Services
5.5 Data Analysis and Storage
6. NGS-based RNA Sequencing Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 Sequencing by Synthesis
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Ion Semiconductor Sequencing
6.4 Single-Molecule Real-Time Sequencing
6.5 Nanopore Sequencing
7. NGS-based RNA Sequencing Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Drug Discovery and Development
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Clinical Diagnostics
7.4 Biomarker and Translational Research
7.5 Basic and Academic Research
7.6 Others
8. NGS-based RNA Sequencing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 NGS-based RNA Sequencing Market Size & Forecast, By Product and Service, 2022–2035
8.2.3 NGS-based RNA Sequencing Market Size & Forecast, By Technology, 2022–2035
8.2.4 NGS-based RNA Sequencing Market Size & Forecast, By Application, 2022–2035
8.2.5 NGS-based RNA Sequencing Market Size & Forecast, By Country, 2022–2035
8.2.5.1 USA
8.2.5.2 Canada
8.3 Europe
8.3.1 Key Trends
8.3.2 NGS-based RNA Sequencing Market Size & Forecast, By Product and Service, 2022–2035
8.3.3 NGS-based RNA Sequencing Market Size & Forecast, By Technology, 2022–2035
8.3.4 NGS-based RNA Sequencing Market Size & Forecast, By Application, 2022–2035
8.3.5 NGS-based RNA Sequencing Market Size & Forecast, By Country, 2022–2035
8.3.5.1 Germany
8.3.5.2 UK
8.3.5.3 France
8.3.5.4 Italy
8.3.5.5 Spain
8.3.5.6 Russia
8.3.5.7 Poland
8.3.5.8 Rest of Europe
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 NGS-based RNA Sequencing Market Size & Forecast, By Product and Service, 2022–2035
8.4.3 NGS-based RNA Sequencing Market Size & Forecast, By Technology, 2022–2035
8.4.4 NGS-based RNA Sequencing Market Size & Forecast, By Application, 2022–2035
8.4.5 NGS-based RNA Sequencing Market Size & Forecast, By Country, 2022–2035
8.4.5.1 China
8.4.5.2 India
8.4.5.3 Japan
8.4.5.4 South Korea
8.4.5.5 Australia
8.4.5.6 ASEAN Countries
8.4.5.7 Rest of Asia-Pacific
8.5 Latin America
8.5.1 Key Trends
8.5.2 NGS-based RNA Sequencing Market Size & Forecast, By Product and Service, 2022–2035
8.5.3 NGS-based RNA Sequencing Market Size & Forecast, By Technology, 2022–2035
8.5.4 NGS-based RNA Sequencing Market Size & Forecast, By Application, 2022–2035
8.5.5 NGS-based RNA Sequencing Market Size & Forecast, By Country, 2022–2035
8.5.5.1 Brazil
8.5.5.2 Argentina
8.5.5.3 Mexico
8.5.5.4 Colombia
8.5.5.5 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 NGS-based RNA Sequencing Market Size & Forecast, By Product and Service, 2022–2035
8.6.3 NGS-based RNA Sequencing Market Size & Forecast, By Technology, 2022–2035
8.6.4 NGS-based RNA Sequencing Market Size & Forecast, By Application, 2022–2035
8.6.5 NGS-based RNA Sequencing Market Size & Forecast, By Country, 2022–2035
8.6.5.1 UAE
8.6.5.2 Saudi Arabia
8.6.5.3 Qatar
8.6.5.4 South Africa
8.6.5.5 Rest of Middle East & Africa
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Year-Wise Strategies & Development, 2022–2026
9.3 Market Share Analysis, 2025
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Illumina
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 Geographical Presence
9.6.1.5 SWOT Analysis
9.6.2 Thermo Fisher Scientific
9.6.3 Pacific Biosciences
9.6.4 Oxford Nanopore Technologies
9.6.5 10x Genomics
9.6.6 MGI Tech
9.6.7 QIAGEN
9.6.8 Agilent Technologies
9.6.9 Roche
9.6.10 Bio-Rad Laboratories
9.6.11 Takara Bio
9.6.12 Element Biosciences
9.6.13 Bruker
9.6.14 Ultima Genomics
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
Frequently Asked Questions
The market was valued at USD 4.32 Billion in 2025 and is projected to reach USD 22.46 Billion by 2035.
The market is expected to register a CAGR of 17.92% from 2026 to 2035.
North America led the market with a 44.60% share in 2025.
Asia Pacific is expected to grow the fastest, at a CAGR of 19.06% from 2026 to 2035.
RNA-seq platforms and consumables led the product and service segment with a 53.40% share in 2025, and drug discovery and development led the application segment.